BC3195 in Combination With Pembrolizumab in Participants With Locally Advanced or Metastatic Solid Tumors
Clinical trial NCT07469774 · RECRUITING
Trial details
- NCT number
- NCT07469774
- Sponsor
- Biocity Biopharmaceutics Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-31
- Primary completion
- 2027-12-31
- Enrollment
- 111
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.